These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 1467362

  • 1. A VLA-4 alpha-chain specific monoclonal antibody enhances CD3-induced IL-2/IL-2 receptor-dependent T-cell proliferation.
    Udagawa T, McIntyre BW.
    Lymphokine Cytokine Res; 1992 Oct; 11(5):193-9. PubMed ID: 1467362
    [Abstract] [Full Text] [Related]

  • 2. Mechanisms by which accessory cells contribute in growth of resting T lymphocytes initiated by OKT3 antibody.
    Palacios R.
    Eur J Immunol; 1985 Jul; 15(7):645-51. PubMed ID: 3924633
    [Abstract] [Full Text] [Related]

  • 3. Requirements for T cell activation by OKT3 monoclonal antibody: role of modulation of T3 molecules and interleukin 1.
    Schwab R, Crow MK, Russo C, Weksler ME.
    J Immunol; 1985 Sep; 135(3):1714-8. PubMed ID: 3926880
    [Abstract] [Full Text] [Related]

  • 4. Evidence for IL-2 independent proliferation in human T cells.
    Laing TJ, Weiss A.
    J Immunol; 1988 Feb 15; 140(4):1056-62. PubMed ID: 2830333
    [Abstract] [Full Text] [Related]

  • 5. Fibronectin promotes proliferation of naive and memory T cells by signaling through both the VLA-4 and VLA-5 integrin molecules.
    Davis LS, Oppenheimer-Marks N, Bednarczyk JL, McIntyre BW, Lipsky PE.
    J Immunol; 1990 Aug 01; 145(3):785-93. PubMed ID: 1695644
    [Abstract] [Full Text] [Related]

  • 6. Differences in the stimulating capacity of immobilized anti-CD3 monoclonal antibodies: variable dependence on interleukin-1 as a helper signal for T-cell activation.
    Verwilghen J, Baroja ML, Van Vaeck F, Van Damme J, Ceuppens JL.
    Immunology; 1991 Feb 01; 72(2):269-76. PubMed ID: 1826671
    [Abstract] [Full Text] [Related]

  • 7. Activation of resting T lymphocytes by anti-CD3 (T3) antibodies in the absence of monocytes.
    Tsoukas CD, Landgraf B, Bentin J, Valentine M, Lotz M, Vaughan JH, Carson DA.
    J Immunol; 1985 Sep 01; 135(3):1719-23. PubMed ID: 3926881
    [Abstract] [Full Text] [Related]

  • 8. Monoclonal antibodies to the CD5 antigen can provide the necessary second signal for activation of isolated resting T cells by solid-phase-bound OKT3.
    Ceuppens JL, Baroja ML.
    J Immunol; 1986 Sep 15; 137(6):1816-21. PubMed ID: 3091691
    [Abstract] [Full Text] [Related]

  • 9. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
    Woods M, Guy R, Waldmann H, Glennie M, Alexander DR.
    Cell Immunol; 1998 May 01; 185(2):101-13. PubMed ID: 9636688
    [Abstract] [Full Text] [Related]

  • 10. Costimulation of proliferative responses of resting CD4+ T cells by the interaction of VLA-4 and VLA-5 with fibronectin or VLA-6 with laminin.
    Shimizu Y, van Seventer GA, Horgan KJ, Shaw S.
    J Immunol; 1990 Jul 01; 145(1):59-67. PubMed ID: 1972721
    [Abstract] [Full Text] [Related]

  • 11. Costimulatory signals modulate the antiproliferative effects of agents that elevate cAMP in T cells.
    Bartik MM, Bauman GP, Brooks WH, Roszman TL.
    Cell Immunol; 1994 Oct 01; 158(1):116-30. PubMed ID: 8087859
    [Abstract] [Full Text] [Related]

  • 12. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
    de Waal Malefyt R, Yssel H, de Vries JE.
    J Immunol; 1993 Jun 01; 150(11):4754-65. PubMed ID: 7684412
    [Abstract] [Full Text] [Related]

  • 13. Specific inhibition of OKT3-driven T-cell mitogenesis by an anti HLA-class I monoclonal antibody.
    Beckman I, Xiaoning X, Bradley J.
    Immunology; 1988 Nov 01; 65(3):373-8. PubMed ID: 3264808
    [Abstract] [Full Text] [Related]

  • 14. Immobilized anti-CD3 monoclonal antibodies induce accessory cell-independent lymphokine production, proliferation and helper activity in human T lymphocytes.
    van Lier RA, Brouwer M, Rebel VI, van Noesel CJ, Aarden LA.
    Immunology; 1989 Sep 01; 68(1):45-50. PubMed ID: 2530156
    [Abstract] [Full Text] [Related]

  • 15. Analysis of the mechanisms of T cell-dependent polyclonal activation of human B cells. Induction of human B cell responses by fixed activated T cells.
    Tohma S, Lipsky PE.
    J Immunol; 1991 Apr 15; 146(8):2544-52. PubMed ID: 1707911
    [Abstract] [Full Text] [Related]

  • 16. T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis.
    Hombach A, Sent D, Schneider C, Heuser C, Koch D, Pohl C, Seliger B, Abken H.
    Cancer Res; 2001 Mar 01; 61(5):1976-82. PubMed ID: 11280755
    [Abstract] [Full Text] [Related]

  • 17. Control of T lymphocyte activation and IL-2 receptor expression by endogenously secreted lymphokines.
    Pimentel-Muiños FX, Muñoz-Fernández MA, Fresno M.
    J Immunol; 1994 Jun 15; 152(12):5714-22. PubMed ID: 8207202
    [Abstract] [Full Text] [Related]

  • 18. Induction of interleukin 2 receptiveness and proliferation in resting peripheral T cells by monoclonal anti-CD3 (T3) antibodies does not require the presence of macrophages.
    Stingl LA, Sinska A, Landesmann U, Smolen JS.
    Clin Exp Immunol; 1987 Apr 15; 68(1):146-55. PubMed ID: 3115639
    [Abstract] [Full Text] [Related]

  • 19. Accessory cell independent proliferation of human T4 cells stimulated by immobilized monoclonal antibodies to CD3.
    Geppert TD, Lipsky PE.
    J Immunol; 1987 Mar 15; 138(6):1660-6. PubMed ID: 3102594
    [Abstract] [Full Text] [Related]

  • 20. Characterization of OKT3-initiated lymphokine-activated effectors expanded with interleukin 2 and tumor necrosis factor alpha.
    Yang SC, Owen-Schaub LB, Roth JA, Grimm EA.
    Cancer Res; 1990 Jun 15; 50(12):3526-32. PubMed ID: 2160321
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.